UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
40 hedge funds and large institutions have $5.87M invested in Unity Biotechnology in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 42 → 40 (-2)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
30% less capital invested
Capital invested by funds: $8.4M → $5.87M (-$2.53M)
Holders
40
Holding in Top 10
3
Calls
$71K
Puts
$23K
Top Buyers
| 1 | +$113K | |
| 2 | +$73.7K | |
| 3 | +$39.8K | |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$29.3K |
| 5 |
Squarepoint
New York
|
+$22.9K |
Top Sellers
| 1 | -$1.33M | |
| 2 | -$199K | |
| 3 | -$59.2K | |
| 4 |
Jane Street
New York
|
-$54.9K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$49.2K |